Haemophilia

Papers
(The H4-Index of Haemophilia is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
The detrimental effects of iron to the joint; aggravation by inflammation84
AHP Oral Abstracts54
CCS_Book of abstracts52
43
Women and girls with haemophilia receiving care at specialized haemophilia treatment centres in the United States42
Descriptive analysis of bleeding symptoms in haemophilia carriers enrolled in the ATHNdataset32
Into a brave new world: Haemophilia A & von Willebrand Disease Surgery with novel therapies27
A systematic review of adeno‐associated virus gene therapy clinical trials for HIV – A potential solution for patients with haemophilia and HIV?26
The importance and evolution of bleeding disorder registries25
Haemophilia B, severe childhood obesity and other extra‐haematological features associated with similar 4Mb‐deletions on Xq27: Clinical findings, molecular insights and literature update25
The effects of emicizumab on in vitro coagulation and fibrinolysis parameters in patients with disseminated intravascular coagulation with and without addition of anti‐FVIII antibody25
Effectiveness of therapeutic exercise and cognitive‐behavioural therapy combined protocol on functionality, pain and joint health in people with haemophilia: Secondary analysis of a controlled trial24
Demographics, clinical profile and treatment landscape of patients with haemophilia B in China23
Is it time for patient involvement in Haemophilia?23
Direct transfer of data of people with haemophilia from the Thai Haemophilia Treatment Centre Registry to the World Bleeding Disorders Registry of the World Federation of Hemophilia22
The legacy of haemophilia: Memories and reflections from three survivors21
Total joint arthroplasty in the patients with haemophilia: General or neuraxial anaesthesia?21
Health‐related quality of life among adults with haemophilia in China: A comparison with age‐matched general population20
Developing a Two‐Sided Decision Box to Facilitate Shared Decision‐Making for Switching From Conventional to Pharmacokinetic‐Tailored Prophylaxis in Haemophilia19
Haemophilia management and treatment: An Italian survey on patients’, caregivers’ and clinicians’ point of view19
Issue Information19
Targeting higher factor VIII levels for prophylaxis in haemophilia A: a narrative review19
Recommendations for Psychosocial Support during Gene Therapy: Results From an EAHAD Interdisciplinary Roundtable19
How to assess, detect, and manage joint involvement in the era of transformational therapies: Role of point‐of‐care ultrasound19
0.059926986694336